Evolus EOLS
NASDAQ EOLS
$6.74 -0.24 (-3.44%)
As of: Nov 10, 2026 · 3:09 PM EST

Evolus (EOLS) Notes Payables (2017 - 2021)

Updated

Analysis

Evolus (EOLS) Notes Payables (2017 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Evolus 455.33 Mn 264.84 Mn 50.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 19.95 Mn
Jun 30, 2021 19.65 Mn
Mar 31, 2021 19.35 Mn
Dec 31, 2020 19.07 Mn
Dec 31, 2017 138.69 Mn
API Access

Evolus Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=EOLS&period=max&api_key=YOUR_API_KEY